Inari Medical, Inc. (NARI)
NASDAQ: NARI · Real-Time Price · USD
55.45
+1.04 (1.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
Inari Medical Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Inari Medical stock have an average target of 62.33, with a low estimate of 47 and a high estimate of 75. The average target predicts an increase of 12.41% from the current stock price of 55.45.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inari Medical stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 3 | 3 | 3 | 3 | 4 |
| Hold | 3 | 3 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $50 → $63 | Hold | Maintains | $50 → $63 | +13.62% | Dec 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $75 | Buy | Initiates | $75 | +35.26% | Dec 17, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 30, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $46 → $50 | Hold | Maintains | $46 → $50 | -9.83% | Oct 29, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $50 → $52 | Hold | Maintains | $50 → $52 | -6.22% | Oct 29, 2024 |
Financial Forecast
Revenue This Year
615.16M
from 493.63M
Increased by 24.62%
Revenue Next Year
727.15M
from 615.16M
Increased by 18.21%
EPS This Year
-0.76
from -0.03
EPS Next Year
0.14
from -0.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 634.2M | 770.1M | 929.7M | |||
| Avg | 615.2M | 727.2M | 851.5M | |||
| Low | 590.2M | 685.2M | 792.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 28.5% | 25.2% | 27.9% | |||
| Avg | 24.6% | 18.2% | 17.1% | |||
| Low | 19.6% | 11.4% | 9.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.69 | 0.87 | 1.73 | |||
| Avg | -0.76 | 0.14 | 0.51 | |||
| Low | -0.95 | -1.68 | -1.89 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 1,113.2% | |||
| Avg | - | - | 257.9% | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.